Filling the silent void: genetic therapies for hearing impairment
- PMID: 23304527
- PMCID: PMC3529436
- DOI: 10.1155/2012/748698
Filling the silent void: genetic therapies for hearing impairment
Abstract
The inner ear cytoarchitecture forms one of the most intricate and delicate organs in the human body and is vulnerable to the effects of genetic disorders, aging, and environmental damage. Owing to the inability of the mammalian cochlea to regenerate sensory hair cells, the loss of hair cells is a leading cause of deafness in humans. Millions of individuals worldwide are affected by the emotionally and financially devastating effects of hearing impairment (HI). This paper provides a brief introduction into the key role of genes regulating inner ear development and function. Potential future therapies that leverage on an improved understanding of these molecular pathways are also described in detail.
References
-
- Raphael Y, Altschuler RA. Structure and innervation of the cochlea. Brain Research Bulletin. 2003;60(5-6):397–422. - PubMed
-
- VAN CAMP GAS. R.J.H., Hereditary Hearing Loss, 2012, http://hereditaryhearingloss.org/
-
- Friedman LM, Dror AA, Avraham KB. Mouse models to study inner ear development and hereditary hearing loss. International Journal of Developmental Biology. 2007;51(6-7):609–631. - PubMed
-
- DeStefano AL, Gates GA, Heard-Costa N, Myers RH, Baldwin CT. Genomewide linkage analysis to presbycusis in the Framingham Heart Study. Archives of Otolaryngology. 2003;129(3):285–289. - PubMed
LinkOut - more resources
Full Text Sources
